Huron Consul Stock Price, News & Analysis

Huron (NASDAQ: HURN) is set to release its financial results for the first quarter ending March 31, 2022, after market close on May 3, 2022. CEO James H. Roth, CFO John D. Kelly, and COO C. Mark Hussey will discuss the results in a conference call at 5:00 p.m. ET on the same day. The call will be webcast on Huron’s official website, with a replay available for 90 days. Huron specializes in professional services, helping clients implement strategies, enhance operations, and drive digital transformation.

Huron (NASDAQ: HURN) held a virtual Investor Day to present its growth strategy and financial goals through 2025.

The strategy focuses on enhancing revenue and profitability with key initiatives in:

• Healthcare and Education growth
• Expansion in Commercial Industries
• Strengthening Digital Capabilities
• Margin Expansion and improved EPS growth

The company targets low double-digit revenue growth, mid-teen adjusted EBITDA margins, and high-teen adjusted EPS growth by 2025.

Huron (NASDAQ: HURN) announced CEO James H. Roth will step down on December 31, 2022, after 13 years in that role, becoming vice chairman of the Board. C. Mark Hussey, current president and COO, will take over as CEO on January 1, 2023. Under Roth’s leadership, Huron nearly doubled its revenue to over $900 million in 2021 and expanded its workforce from 2,000 to over 4,500 globally. An Investor Day is set for March 29, 2022, to discuss the company's strategy and transition.

Huron (NASDAQ: HURN) announced the election of Peter Markell to its board of directors, increasing board membership to seven. Markell brings extensive financial expertise, having managed $14 billion in operations while serving as CFO at Mass General Brigham. His experience in healthcare and higher education aligns with Huron’s strategic goals. The board aims to enhance its capabilities further with new members to reflect diverse perspectives and better serve clients.

Huron's Q4 2021 revenues surged by 25.2% to $248.3 million, up from $198.3 million in Q4 2020. The company reported a net income of $31.1 million, reversing a net loss of $6.1 million the previous year, aided by a $23.7 million gain from the sale of its Life Sciences business. Adjusted EBITDA grew 71.7% to $29.3 million, while diluted EPS improved to $1.45 from a loss of $0.28. For 2021, total revenues reached $905.6 million, up 7.3%, with guidance for 2022 set between $970 million to $1.03 billion.

Global professional services firm Huron (NASDAQ: HURN) will announce its financial results for the fourth quarter and full year ended Dec. 31, 2021, after market close on Thursday, Feb. 24, 2022. A conference call will follow at 5:00 p.m. Eastern Time featuring CEO James H. Roth and CFO John D. Kelly. Additionally, Huron is hosting a virtual Investor Day on Tuesday, Mar. 29, 2022, at 9:00 a.m. Eastern Time, to discuss company strategy with its leadership team. Details for both events will be available on Huron's website.

Huron (NASDAQ: HURN) announced the promotion of 26 managing directors and principals to enhance client support during transformation initiatives. CEO James H. Roth commended their dedication to delivering results and exemplifying the firm's values. The promotions reflect Huron's commitment to growth and operational excellence, particularly in healthcare and education sectors, as these leaders bring extensive experience in managing performance improvements, optimizing healthcare operations, and guiding strategic initiatives.

Huron (NASDAQ: HURN) has successfully acquired Perception Health Inc., enhancing its healthcare predictive analytics and data capabilities. This strategic acquisition aims to help clients leverage data for improved patient care and decision-making. Huron's CEO, James H. Roth, expressed enthusiasm about integrating Perception Health's expertise to better identify and manage patient risks. Post-acquisition, Perception Health will be included in Huron's Healthcare operating segment, reinforcing their commitment to data-driven healthcare solutions.

Huron (NASDAQ: HURN) announced its agreement to acquire Perception Health Inc., a predictive analytics firm focused on healthcare. This acquisition aims to enhance Huron's capabilities in delivering data insights for improved clinical and business decisions. With Perception Health's advanced analytics and data platform, Huron seeks to support healthcare providers in lowering costs and improving patient outcomes. The acquisition is expected to close in December, although specific terms were not disclosed.